MedImmune, AstraZeneca’s global biologics research and development arm, and the University of Maryland, Baltimore (UMB) have announced they have entered into a five-year, $6 million collaboration to drive novel bioscience research in the state of Maryland. This agreement represents the first of several planned innovative collaborations by MedImmune to actively work with leading regional research […]
umd baltimore
September 26, 2013 |
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia